Improved survival with regular surveillance imaging in patients with primary sclerosing cholangitis

Natassia Tan(The Alfred Hospital), Ammar Majeed(Monash University), Stuart K. Roberts(The Alfred Hospital), Thomas Worland(Austin Health), Amanda Nicoll(The Royal Melbourne Hospital), Nicholas Hannah(The Royal Melbourne Hospital), Kate D. Lynch(Royal Adelaide Hospital), Tobie Abrahams(St Vincent's Health), William Kemp(The Alfred Hospital), John Lubel(Eastern Health), Paul Gow(The University of Melbourne), R.G. Madden, Tanya Lee(St Vincent's Hospital Melbourne), Natalie Ngu(Monash Health), Anouk Dev(Monash Medical Centre), Keval Pandya(Royal Prince Alfred Hospital), Elliot Freeman(Alfred Health), Siddarth Sood, Ken Liu, Sally Bell, Kathryn Gazelakis(Monash Health), Alexander Thompson(The University of Melbourne), Zina Valaydon(The University of Melbourne)
Journal of Hepatology
June 1, 2023
10.1016/s0168-8278(23)01029-2
Cited by 0

Related Papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
|The Lancet|2023|514
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
|Hepatology|2010|409
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
|AIDS|2010|202
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress
|Journal of Hepatology|2017|151
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123